Font Size
A
A
A

Current and Future Medications for Hepatitis C (cont.)

Investigational drugs

Researchers are studying the following drugs for use in treating hepatitis C:

  • Thymosin alpha-1 (Zadaxin, by SciClone) is a protein that enhances the body’s immune system to counteract viruses.

  • BILN 2061 (by Boehringer Ingelheim) is an HCV protease inhibitor that blocks an enzyme released by HCV, thereby inhibiting viral replication.

  • ISIS 14803 (by Isis Pharmaceuticals and Elan) is a nucleoside analog that disrupts proteins during viral cell division, thereby decreasing the ability of HCV to multiply.

  • Other interferons are being investigated, including recombinant interferon beta-1a (by Serono Lab), omega interferon (by BioMedicines), and VX-497 (by Vertex Pharmaceuticals).



Next: Support Groups and Counseling »

Printer-Friendly Format  |  Email to a Friend

Women's Health

Find out what women really need.

Are You Depressed? Take the Quiz


Read What Your Physician is Reading on eMedicine

Hepatitis C »

The World Health Organization (WHO) estimates 170 million individuals worldwide are infected with hepatitis C virus (HCV).

Read More on eMedicine »

Medical Dictionary